Your current location: Home
> News
* { font-family: Tahoma, Arial, Helvetica; } html { overflow-y: scroll; } body { background: #FFFFFF; background-repeat: no-repeat; -o-background-size:99% auto; -webkit-background-size:99% auto; -moz-background-size:99% auto; background-size:99% auto; margin: 0px 0 10px 10px; padding: 0px; font-size: 14px; } mg { padding: 1px 1px 1px 1px; background: #ffffff; } #banner { width: 450px; padding-top: 0px; margin-left: 0px; } #banner2, #bannertekst { background: url(/img/artikelen/base/logo.png) no-repeat; background-size: 100% auto; max-width: 320px; height: 98px; padding-top: 0px; margin-right: 0px; margin-top: 20px; } a, a * { color: #464646; text-decoration: underline; } a:hover, a:hover * { color: #464646; } #pagina { position: left; border: 0px solid #000000; color: #464646; width: 90%; margin-left: 10px; /* width: 1200px; */ } #header { position: relative; top: -30px; left: 0px; height: 57px; margin-bottom: 16px; } #content { margin-top: 30px; margin-left: -10px; margin-right: -15px; padding-left: 0px; padding-right: 0px; min-height: 50px; } #bc { color: #6D6E71; font-size: 10px; margin-left: 5px; margin-top: 0px; } #bc a { color: #6D6E71; } #lang { color: #6D6E71; font-size: 10px; float: right; margin-top: 0px; margin-right: 0px; display:block; z-index: 2000; position: relative; } #content table.tlayout { width: 99%; margin: 0 auto; } #content table.tlayout tr td{ vertical-align: top; } #content h1 { color: #000000; border: 0px solid #000000; margin: 0px 0px 6px 0px; padding-left: 0px; font-size: 16px; text-transform: uppercase; margin-bottom:3px; } #footer { padding-left: 0px; padding-right: 0px; /* color: #464646; */ color: #FFFFFF; margin-left: 0px; padding-top: 0px; height: 120px; } #footer a { color: #FA902A; } #footer h3 { color: #000000; text-decoration: underline; margin-bottom:3px; } #textover { position: relative; width: 100%; /* for IE 6 */ } h2 { position: absolute; top: 150px; left: 0px; width: 100%; } .block { border-left: 8px solid #000000; background: #FFFFFF; padding: 3px; margin: 0px 5px 0px 0px; /* border-bottom:0px dashed #b4b4b4; */ /* box-shadow: 5px 5px 5px rgb(80, 80, 80); padding: 5px; border-radius: 5px; */ }
FOOD SAFETY SYSTEM CERTIFICATION 22000 |
(ISO 22000:2018, ISO/TS 22002-5:2019 and additional FSSC 22000 requirements (Version 5.1). |
The Dutch Blood Supply Act is intended to strengthen the quality, safety and availability of blood and blood products from unremunerated voluntary donors in the Netherlands. Responsibility for implementation and maintenance of this programme has been entrusted to Sanquin.
The Plasma Products division processes the plasma supplied by the blood banks into medicines for coagulation and immune disorders. These medicines are called plasma products. Sanquin is a major supplier of medicines for patients in the Netherlands. A variety of isolation techniques produces coagulation factors, protease inhibitors, immunoglobulins and albumin. Sanquin Plasma Products works closely with sister organisations in other countries, such as the Department for Central Fractioning (CAF) in Belgium and the Finnish Red Cross.